InsidersTradesSigma
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Clifton R. LaDuane. Director active across 1 companies, notably Kempharm, INC. Cumulatively, 13 reports have been published. Total volume traded: €38k. The latest transaction was disclosed on 18 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations13 total
€5,7281,200 shares@ €4.773515.0% of flow
Common Stock
SEC:0001437749-22-012932:0·
Ideal exit: 12 Feb 2023 (T+270)
€3,735510 shares@ €7.322623.1% of flow
Common Stock
SEC:0001437749-21-027098·
Ideal exit: 15 Aug 2022 (T+270)
€3,735510 shares@ €7.32269.8% of flow
Common Stock
SEC:0001437749-21-027098:0·
Ideal exit: 15 Aug 2022 (T+270)
€1,738215 shares@ €8.085110.7% of flow
Common Stock
SEC:0001437749-21-022841·
Ideal exit: 26 Jun 2022 (T+270)
€1,738215 shares@ €8.08514.6% of flow
Common Stock
SEC:0001437749-21-022841:0·
Ideal exit: 26 Jun 2022 (T+270)
€6,844935 shares@ €7.3242.3% of flow
Common Stock
SEC:0001437749-21-022431·
Ideal exit: 17 Jun 2022 (T+270)
€6,844935 shares@ €7.3218.0% of flow
Common Stock
SEC:0001437749-21-022431:0·
Ideal exit: 17 Jun 2022 (T+270)
€1,769230 shares@ €7.689410.9% of flow
Common Stock
SEC:0001437749-21-021308·
Ideal exit: 29 May 2022 (T+270)
€1,769230 shares@ €7.68944.6% of flow
Common Stock
SEC:0001437749-21-021308:0·
Ideal exit: 29 May 2022 (T+270)
€88775 shares@ €11.82425.5% of flow
Common Stock
SEC:0001437749-21-015562·
Ideal exit: 20 Mar 2022 (T+270)
€88775 shares@ €11.82422.3% of flow
Common Stock
SEC:0001437749-21-015562:0·
Ideal exit: 20 Mar 2022 (T+270)
€1,212150 shares@ €8.07837.5% of flow
Common Stock
SEC:0001437749-21-013577·
Ideal exit: 21 Feb 2022 (T+270)
€1,212150 shares@ €8.07833.2% of flow
Common Stock
SEC:0001437749-21-013577:0·
Ideal exit: 21 Feb 2022 (T+270)
13 of 13 declarations
About Clifton R. LaDuane
Clifton R. LaDuane is a director at Kempharm, INC.
